ONTOLOGY REPORT - ANNOTATIONS
| Term: | zinc sulfate |
|
| Accession: | CHEBI:35176
|
browse the term
|
| Definition: | A metal sulfate compound having zinc(2+) as the counterion. |
| Synonyms: | related_synonym: | InChI=1S/H2O4S.Zn/c1-5(2,3)4;/h(H2,1,2,3,4);/q;+2/p-2; InChIKey=NWONKYPBYAMBJT-UHFFFAOYSA-L; O4SZn; ZnSO4; [Zn++].[O-]S([O-])(=O)=O; zinc sulfate (1:1); zinc sulfate anhydrous; zinc sulphate; zinc(2+) sulfate; zinc(II) sulfate |
| | xref_casrn: | 7733-02-0 |
| | xref: | ChEMBL:774880 "ChEMBL COMPOUND"; ChemIDplus:7733-02-0 "CAS Registry Number"; CiteXplore:10469300 "PubMed citation"; CiteXplore:8566016 "PubMed citation"; Gmelin:18165 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D019287 |
| | xref: | Wikipedia:Zinc_Sulfate "Wikipedia" |
|
|
zinc sulfate
|
| G |
2700081O15Rik |
RIKEN cDNA 2700081O15 gene |
|
increases expression |
ISO |
19 |
7,492,115 |
7,500,394 |
RGD:6480464 |
CTD |
| G |
3830406C13Rik |
RIKEN cDNA 3830406C13 gene |
|
decreases expression |
ISO |
14 |
13,116,723 |
13,135,745 |
RGD:6480464 |
CTD |
| G |
A230050P20Rik |
RIKEN cDNA A230050P20 gene |
|
decreases expression |
ISO |
9 |
20,673,086 |
20,678,751 |
RGD:6480464 |
CTD |
| G |
Abcc10 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 10 |
|
increases expression |
ISO |
17 |
46,440,179 |
46,464,972 |
RGD:6480464 |
CTD |
| G |
Abcc9 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
|
decreases expression |
ISO |
6 |
142,536,382 |
142,650,794 |
RGD:6480464 |
CTD |
| G |
Abcg1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
|
increases expression |
ISO |
17 |
31,194,639 |
31,254,929 |
RGD:6480464 |
CTD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
decreases expression |
ISO |
9 |
122,260,734 |
122,290,641 |
RGD:6480464 |
CTD |
| G |
Acacb |
acetyl-Coenzyme A carboxylase beta |
|
increases expression |
ISO |
5 |
114,615,527 |
114,700,767 |
RGD:6480464 |
CTD |
| G |
Acads |
acyl-Coenzyme A dehydrogenase, short chain |
|
increases expression |
ISO |
5 |
115,560,308 |
115,569,322 |
RGD:6480464 |
CTD |
| G |
Acadsb |
acyl-Coenzyme A dehydrogenase, short/branched chain |
|
increases expression |
ISO |
7 |
138,554,115 |
138,589,725 |
RGD:6480464 |
CTD |
| G |
Acadvl |
acyl-Coenzyme A dehydrogenase, very long chain |
|
increases expression |
ISO |
11 |
69,823,694 |
69,828,909 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
EXP |
9 |
21,931,171 |
21,940,190 |
RGD:6480464 |
CTD |
| G |
Acp5 |
acid phosphatase 5, tartrate resistant |
|
multiple interactions |
EXP |
9 |
21,931,171 |
21,940,190 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
ISO |
2 |
113,873,025 |
113,878,547 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
multiple interactions |
EXP |
3 |
137,940,609 |
137,953,655 |
RGD:6480464 |
CTD |
| G |
Adm |
adrenomedullin |
|
increases expression |
ISO |
7 |
117,771,183 |
117,773,333 |
RGD:6480464 |
CTD |
| G |
Aifm1 |
apoptosis-inducing factor, mitochondrion-associated 1 |
|
multiple interactions |
ISO |
X |
45,828,121 |
45,866,603 |
RGD:6480464 |
CTD |
| G |
Akr1c21 |
aldo-keto reductase family 1, member C21 |
|
increases expression |
ISO |
13 |
4,573,321 |
4,585,789 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
EXP |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
EXP |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
multiple interactions |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Akt1 |
thymoma viral proto-oncogene 1 |
|
increases phosphorylation |
ISO |
12 |
113,892,032 |
113,912,487 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate, delta-, dehydratase |
|
multiple interactions |
ISO |
4 |
62,170,204 |
62,181,097 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate, delta-, dehydratase |
|
multiple interactions |
ISO |
4 |
62,170,204 |
62,181,097 |
RGD:6480464 |
CTD |
| G |
Alb |
albumin |
|
decreases expression |
ISO |
5 |
90,889,915 |
90,905,629 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2, mitochondrial |
|
multiple interactions |
EXP |
5 |
122,017,696 |
122,043,833 |
RGD:6480464 |
CTD |
| G |
Aldh3a1 |
aldehyde dehydrogenase family 3, subfamily A1 |
|
multiple interactions |
EXP |
11 |
61,022,244 |
61,031,920 |
RGD:6480464 |
CTD |
| G |
Aldob |
aldolase B, fructose-bisphosphate |
|
decreases expression |
ISO |
4 |
49,548,867 |
49,562,355 |
RGD:6480464 |
CTD |
| G |
Angpt4 |
angiopoietin 4 |
|
increases expression |
ISO |
2 |
151,737,068 |
151,770,390 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
decreases expression |
ISO |
9 |
69,301,490 |
69,339,592 |
RGD:6480464 |
CTD |
| G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
|
decreases expression |
ISO |
11 |
83,116,199 |
83,218,537 |
RGD:6480464 |
CTD |
| G |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
|
decreases expression |
ISO |
7 |
112,706,998 |
112,730,049 |
RGD:6480464 |
CTD |
| G |
Apc2 |
adenomatosis polyposis coli 2 |
|
decreases expression |
ISO |
10 |
79,764,565 |
79,781,001 |
RGD:6480464 |
CTD |
| G |
Aprt |
adenine phosphoribosyl transferase |
|
decreases expression |
ISO |
8 |
125,098,537 |
125,100,807 |
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
increases expression |
ISO |
6 |
55,286,293 |
55,298,549 |
RGD:6480464 |
CTD |
| G |
Arhgef18 |
rho/rac guanine nucleotide exchange factor (GEF) 18 |
|
increases expression |
ISO |
8 |
3,393,008 |
3,456,600 |
RGD:6480464 |
CTD |
| G |
Arhgef3 |
Rho guanine nucleotide exchange factor (GEF) 3 |
|
decreases expression |
ISO |
14 |
28,051,225 |
28,217,090 |
RGD:6480464 |
CTD |
| G |
Art1 |
ADP-ribosyltransferase 1 |
|
decreases expression |
ISO |
7 |
109,250,257 |
109,259,662 |
RGD:6480464 |
CTD |
| G |
Art3 |
ADP-ribosyltransferase 3 |
|
increases expression |
ISO |
5 |
92,760,867 |
92,843,654 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
increases phosphorylation |
ISO |
2 |
73,654,578 |
73,730,685 |
RGD:6480464 |
CTD |
| G |
Atp2c1 |
ATPase, Ca++-sequestering |
|
increases expression |
ISO |
9 |
105,313,692 |
105,397,447 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene 1 |
|
decreases expression |
ISO |
4 |
40,883,431 |
40,895,327 |
RGD:6480464 |
CTD |
| G |
Baz1b |
bromodomain adjacent to zinc finger domain, 1B |
|
increases expression |
ISO |
5 |
135,663,193 |
135,721,999 |
RGD:6480464 |
CTD |
| G |
Bbc3 |
BCL2 binding component 3 |
|
increases expression |
ISO |
7 |
16,894,932 |
16,903,683 |
RGD:6480464 |
CTD |
| G |
Bbs9 |
Bardet-Biedl syndrome 9 (human) |
|
decreases expression |
ISO |
9 |
22,280,159 |
22,692,724 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
increases expression |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B cell leukemia/lymphoma 2 |
|
multiple interactions |
ISO |
1 |
108,434,756 |
108,610,867 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
BCL2-like 1 |
|
increases expression |
ISO |
2 |
152,606,404 |
152,657,418 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain derived neurotrophic factor |
|
increases expression |
ISO |
2 |
109,514,857 |
109,567,200 |
RGD:6480464 |
CTD |
| G |
Bglap |
bone gamma carboxyglutamate protein |
|
multiple interactions |
EXP |
3 |
88,187,417 |
88,188,386 |
RGD:6480464 |
CTD |
| G |
Bglap3 |
bone gamma-carboxyglutamate protein 3 |
|
multiple interactions |
EXP |
3 |
88,172,539 |
88,173,642 |
RGD:6480464 |
CTD |
| G |
Blk |
B lymphoid kinase |
|
increases expression |
ISO |
14 |
63,991,674 |
64,036,024 |
RGD:6480464 |
CTD |
| G |
Brd1 |
bromodomain containing 1 |
|
increases expression |
ISO |
15 |
88,517,465 |
88,564,649 |
RGD:6480464 |
CTD |
| G |
Brd8 |
bromodomain containing 8 |
|
increases expression |
ISO |
18 |
34,758,269 |
34,784,464 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
multiple interactions |
EXP |
17 |
57,343,396 |
57,367,559 |
RGD:6480464 |
CTD |
| G |
Cabp4 |
calcium binding protein 4 |
|
increases expression |
ISO |
19 |
4,135,423 |
4,139,609 |
RGD:6480464 |
CTD |
| G |
Cacna1c |
calcium channel, voltage-dependent, L type, alpha 1C subunit |
|
increases expression |
ISO |
6 |
118,542,314 |
119,146,427 |
RGD:6480464 |
CTD |
| G |
Cadps |
Ca2+-dependent secretion activator |
|
increases expression |
ISO |
14 |
13,205,077 |
13,655,593 |
RGD:6480464 |
CTD |
| G |
Calm1 |
calmodulin 1 |
|
decreases expression |
ISO |
12 |
101,437,751 |
101,448,016 |
RGD:6480464 |
CTD |
| G |
Calm3 |
calmodulin 3 |
|
decreases expression |
ISO |
7 |
17,481,248 |
17,501,262 |
RGD:6480464 |
CTD |
| G |
Capn10 |
calpain 10 |
|
decreases expression |
ISO |
1 |
94,830,985 |
94,844,525 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases cleavage |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
8 |
47,702,803 |
47,724,071 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
ISO |
2 |
103,294,061 |
103,325,310 |
RGD:6480464 |
CTD |
| G |
Ccdc130 |
coiled-coil domain containing 130 |
|
increases expression |
ISO |
8 |
86,781,694 |
86,794,259 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
7 |
152,115,836 |
152,125,830 |
RGD:6480464 |
CTD |
| G |
Ccnd2 |
cyclin D2 |
|
decreases expression |
ISO |
6 |
127,075,726 |
127,101,066 |
RGD:6480464 |
CTD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
increases expression |
ISO |
9 |
124,016,922 |
124,023,879 |
RGD:6480464 |
CTD |
| G |
Cd22 |
CD22 antigen |
|
increases expression |
ISO |
7 |
31,650,423 |
31,665,361 |
RGD:6480464 |
CTD |
| G |
Cd36 |
CD36 antigen |
|
increases expression |
ISO |
5 |
17,287,508 |
17,394,777 |
RGD:6480464 |
CTD |
| G |
Cd8b1 |
CD8 antigen, beta chain 1 |
|
increases expression |
ISO |
6 |
71,272,806 |
71,287,445 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A (P21) |
|
increases expression |
ISO |
17 |
29,227,931 |
29,237,667 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
2 |
167,514,415 |
167,515,918 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
16 |
15,887,379 |
15,889,638 |
RGD:6480464 |
CTD |
| G |
Chrm3 |
cholinergic receptor, muscarinic 3, cardiac |
|
decreases expression |
ISO |
13 |
9,875,859 |
10,360,049 |
RGD:6480464 |
CTD |
| G |
Chuk |
conserved helix-loop-helix ubiquitous kinase |
|
multiple interactions |
EXP |
19 |
44,147,824 |
44,181,967 |
RGD:6480464 |
CTD |
| G |
Cib3 |
calcium and integrin binding family member 3 |
|
decreases expression |
ISO |
8 |
74,728,234 |
74,736,736 |
RGD:6480464 |
CTD |
| G |
Clcn7 |
chloride channel 7 |
|
increases expression |
ISO |
17 |
25,270,339 |
25,299,044 |
RGD:6480464 |
CTD |
| G |
Clcnkb |
chloride channel Kb |
|
decreases expression |
ISO |
4 |
140,960,272 |
140,971,903 |
RGD:6480464 |
CTD |
| G |
Cnbp |
cellular nucleic acid binding protein |
|
increases expression |
ISO |
6 |
87,792,609 |
87,801,100 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
decreases expression |
ISO |
3 |
121,129,459 |
121,161,123 |
RGD:6480464 |
CTD |
| G |
Cntf |
ciliary neurotrophic factor |
|
multiple interactions |
ISO |
19 |
12,838,018 |
12,840,122 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
EXP |
11 |
94,797,584 |
94,813,181 |
RGD:6480464 |
CTD |
| G |
Commd10 |
COMM domain containing 10 |
|
decreases expression |
ISO |
18 |
47,118,530 |
47,247,649 |
RGD:6480464 |
CTD |
| G |
Cox17 |
cytochrome c oxidase assembly protein 17 |
|
decreases expression |
ISO |
16 |
38,347,085 |
38,352,849 |
RGD:6480464 |
CTD |
| G |
Cox8a |
cytochrome c oxidase subunit VIIIa |
|
decreases expression |
ISO |
19 |
7,289,648 |
7,292,106 |
RGD:6480464 |
CTD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
increases expression |
ISO |
19 |
3,323,301 |
3,385,733 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
multiple interactions |
EXP |
1 |
196,929,982 |
196,957,764 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
increases expression |
EXP |
1 |
196,929,982 |
196,957,764 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
affects expression |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
increases phosphorylation |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
1 |
64,579,378 |
64,651,122 |
RGD:6480464 |
CTD |
| G |
Crlf3 |
cytokine receptor-like factor 3 |
|
decreases expression |
ISO |
11 |
79,860,001 |
79,894,457 |
RGD:6480464 |
CTD |
| G |
Cs |
citrate synthase |
|
increases expression |
ISO |
10 |
127,774,888 |
127,799,535 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
3 |
107,543,966 |
107,563,387 |
RGD:6480464 |
CTD |
| G |
Csf1 |
colony stimulating factor 1 (macrophage) |
|
multiple interactions |
EXP |
3 |
107,543,966 |
107,563,387 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
EXP |
3 |
95,303,208 |
95,313,284 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
multiple interactions |
EXP |
3 |
95,303,208 |
95,313,284 |
RGD:6480464 |
CTD |
| G |
Ctsk |
cathepsin K |
|
decreases expression |
EXP |
3 |
95,303,208 |
95,313,284 |
RGD:6480464 |
CTD |
| G |
Ctsl |
cathepsin L |
|
increases expression |
ISO |
13 |
64,464,522 |
64,471,614 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
increases expression |
ISO |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
decreases expression |
ISO |
5 |
91,332,925 |
91,334,964 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
increases expression |
ISO |
5 |
91,188,325 |
91,190,651 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
EXP |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
multiple interactions |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
|
increases expression |
ISO |
7 |
147,949,731 |
147,960,880 |
RGD:6480464 |
CTD |
| G |
Cyp4a10 |
cytochrome P450, family 4, subfamily a, polypeptide 10 |
|
multiple interactions |
EXP |
4 |
115,190,892 |
115,206,254 |
RGD:6480464 |
CTD |
| G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
|
increases expression |
ISO |
4 |
115,297,333 |
115,320,310 |
RGD:6480464 |
CTD |
| G |
Dcaf8 |
DDB1 and CUL4 associated factor 8 |
|
decreases expression |
ISO |
1 |
174,078,146 |
174,126,524 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
10 |
59,412,423 |
59,414,518 |
RGD:6480464 |
CTD |
| G |
Ddx23 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 23 |
|
increases expression |
ISO |
15 |
98,475,938 |
98,493,320 |
RGD:6480464 |
CTD |
| G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
|
increases expression |
ISO |
15 |
76,332,445 |
76,342,248 |
RGD:6480464 |
CTD |
| G |
Dhx58 |
DEXH (Asp-Glu-X-His) box polypeptide 58 |
|
decreases expression |
ISO |
11 |
100,556,198 |
100,565,585 |
RGD:6480464 |
CTD |
| G |
Dicer1 |
dicer 1, ribonuclease type III |
|
increases expression |
ISO |
12 |
105,925,952 |
105,990,162 |
RGD:6480464 |
CTD |
| G |
Drd1a |
dopamine receptor D1A |
|
multiple interactions |
ISO |
13 |
54,146,552 |
54,151,027 |
RGD:6480464 |
CTD |
| G |
Drd2 |
dopamine receptor D2 |
|
multiple interactions |
ISO |
9 |
49,148,767 |
49,215,319 |
RGD:6480464 |
CTD |
| G |
Dstn |
destrin |
|
decreases expression |
ISO |
2 |
143,741,067 |
143,769,060 |
RGD:6480464 |
CTD |
| G |
Dtx3 |
deltex 3 homolog (Drosophila) |
|
increases expression |
ISO |
10 |
126,627,434 |
126,632,765 |
RGD:6480464 |
CTD |
| G |
Dusp5 |
dual specificity phosphatase 5 |
|
decreases expression |
ISO |
19 |
53,603,808 |
53,615,812 |
RGD:6480464 |
CTD |
| G |
Dync1h1 |
dynein cytoplasmic 1 heavy chain 1 |
|
decreases expression |
ISO |
12 |
111,839,605 |
111,905,154 |
RGD:6480464 |
CTD |
| G |
Dync1li2 |
dynein, cytoplasmic 1 light intermediate chain 2 |
|
increases expression |
ISO |
8 |
106,941,574 |
106,966,947 |
RGD:6480464 |
CTD |
| G |
E130309F12Rik |
RIKEN cDNA E130309F12 gene |
|
decreases expression |
ISO |
4 |
49,072,334 |
49,353,133 |
RGD:6480464 |
CTD |
| G |
Eda |
ectodysplasin-A |
|
decreases expression |
ISO |
X |
97,170,945 |
97,596,099 |
RGD:6480464 |
CTD |
| G |
Ednrb |
endothelin receptor type B |
|
decreases expression |
ISO |
14 |
104,213,842 |
104,243,390 |
RGD:6480464 |
CTD |
| G |
Eef2k |
eukaryotic elongation factor-2 kinase |
|
increases expression |
ISO |
7 |
127,986,397 |
128,047,515 |
RGD:6480464 |
CTD |
| G |
Efna1 |
ephrin A1 |
|
increases expression |
ISO |
3 |
89,075,652 |
89,084,873 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
ISO |
3 |
129,380,493 |
129,458,240 |
RGD:6480464 |
CTD |
| G |
Egfl7 |
EGF-like domain 7 |
|
decreases expression |
ISO |
2 |
26,436,576 |
26,448,202 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases phosphorylation |
ISO |
11 |
16,652,206 |
16,813,910 |
RGD:6480464 |
CTD |
| G |
Egln1 |
EGL nine homolog 1 (C. elegans) |
|
increases expression |
ISO |
8 |
127,432,487 |
127,473,154 |
RGD:6480464 |
CTD |
| G |
Ehd1 |
EH-domain containing 1 |
|
increases expression |
ISO |
19 |
6,276,896 |
6,300,096 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
multiple interactions |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Elk1 |
ELK1, member of ETS oncogene family |
|
increases activity |
ISO |
X |
20,510,521 |
20,527,726 |
RGD:6480464 |
CTD |
| G |
Emid1 |
EMI domain containing 1 |
|
increases expression |
ISO |
11 |
5,006,269 |
5,052,225 |
RGD:6480464 |
CTD |
| G |
Epha7 |
Eph receptor A7 |
|
increases expression |
ISO |
4 |
28,740,295 |
28,894,649 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal |
|
increases expression |
ISO |
1 |
182,919,687 |
182,947,626 |
RGD:6480464 |
CTD |
| G |
Ercc1 |
excision repair cross-complementing rodent repair deficiency, complementation group 1 |
|
increases expression |
ISO |
7 |
19,930,420 |
19,941,873 |
RGD:6480464 |
CTD |
| G |
Ergic3 |
ERGIC and golgi 3 |
|
decreases expression |
ISO |
2 |
155,833,861 |
155,844,015 |
RGD:6480464 |
CTD |
| G |
Esd |
esterase D/formylglutathione hydrolase |
|
decreases expression |
ISO |
14 |
75,132,152 |
75,150,250 |
RGD:6480464 |
CTD |
| G |
Exosc7 |
exosome component 7 |
|
decreases expression |
ISO |
9 |
123,022,349 |
123,045,247 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
decreases expression |
ISO |
3 |
10,012,606 |
10,016,610 |
RGD:6480464 |
CTD |
| G |
Fads1 |
fatty acid desaturase 1 |
|
decreases expression |
ISO |
19 |
10,257,378 |
10,271,364 |
RGD:6480464 |
CTD |
| G |
Fam13a |
family with sequence similarity 13, member A |
|
decreases expression |
ISO |
6 |
58,883,530 |
58,974,496 |
RGD:6480464 |
CTD |
| G |
Fcer1a |
Fc receptor, IgE, high affinity I, alpha polypeptide |
|
multiple interactions |
EXP |
1 |
175,151,402 |
175,157,360 |
RGD:6480464 |
CTD |
| G |
Fez1 |
fasciculation and elongation protein zeta 1 (zygin I) |
|
decreases expression |
ISO |
9 |
36,651,244 |
36,686,225 |
RGD:6480464 |
CTD |
| G |
Fgf1 |
fibroblast growth factor 1 |
|
increases expression |
ISO |
18 |
38,998,327 |
39,078,353 |
RGD:6480464 |
CTD |
| G |
Flt1 |
FMS-like tyrosine kinase 1 |
|
increases expression |
ISO |
5 |
148,373,772 |
148,537,564 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
12 |
86,814,851 |
86,818,219 |
RGD:6480464 |
CTD |
| G |
Foxn4 |
forkhead box N4 |
|
increases expression |
ISO |
5 |
114,704,173 |
114,723,770 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
multiple interactions |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
increases phosphorylation |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo1 |
forkhead box O1 |
|
affects localization |
ISO |
3 |
52,072,259 |
52,154,031 |
RGD:6480464 |
CTD |
| G |
Foxo3 |
forkhead box O3 |
|
increases expression |
ISO |
10 |
41,905,592 |
41,996,548 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
multiple interactions |
ISO |
X |
98,449,867 |
98,456,212 |
RGD:6480464 |
CTD |
| G |
Foxo4 |
forkhead box O4 |
|
increases phosphorylation |
ISO |
X |
98,449,867 |
98,456,212 |
RGD:6480464 |
CTD |
| G |
Fzr1 |
fizzy/cell division cycle 20 related 1 (Drosophila) |
|
increases expression |
ISO |
10 |
80,829,624 |
80,841,115 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
multiple interactions |
ISO |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
G6pdx |
glucose-6-phosphate dehydrogenase X-linked |
|
increases expression |
ISO |
X |
71,654,825 |
71,674,500 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible 45 alpha |
|
decreases expression |
ISO |
6 |
66,985,090 |
66,987,401 |
RGD:6480464 |
CTD |
| G |
Gata4 |
GATA binding protein 4 |
|
decreases expression |
ISO |
14 |
63,817,752 |
63,864,097 |
RGD:6480464 |
CTD |
| G |
Gata6 |
GATA binding protein 6 |
|
increases expression |
ISO |
18 |
11,052,508 |
11,085,633 |
RGD:6480464 |
CTD |
| G |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
|
increases expression |
ISO |
19 |
17,400,631 |
17,431,157 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell line derived neurotrophic factor |
|
decreases expression |
ISO |
15 |
7,761,011 |
7,787,575 |
RGD:6480464 |
CTD |
| G |
Gh |
growth hormone |
|
multiple interactions |
ISO |
11 |
106,161,582 |
106,163,124 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
ISO |
15 |
3,267,760 |
3,533,230 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
decreases expression |
ISO |
10 |
56,097,106 |
56,110,225 |
RGD:6480464 |
CTD |
| G |
Glul |
glutamate-ammonia ligase (glutamine synthetase) |
|
increases expression |
ISO |
1 |
155,747,075 |
155,756,844 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
|
decreases activity |
ISO |
2 |
174,109,821 |
174,172,245 |
RGD:6480464 |
CTD |
| G |
Gnb2l1 |
guanine nucleotide binding protein (G protein), beta polypeptide 2 like 1 |
|
decreases expression |
ISO |
11 |
48,613,862 |
48,619,743 |
RGD:6480464 |
CTD |
| G |
Gng11 |
guanine nucleotide binding protein (G protein), gamma 11 |
|
decreases expression |
ISO |
6 |
3,953,987 |
3,958,445 |
RGD:6480464 |
CTD |
| G |
Gpx1 |
glutathione peroxidase 1 |
|
multiple interactions |
EXP |
9 |
108,241,607 |
108,242,671 |
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
multiple interactions |
ISO |
8 |
13,405,081 |
13,421,951 |
RGD:6480464 |
CTD |
| G |
Grk1 |
G protein-coupled receptor kinase 1 |
|
decreases expression |
ISO |
8 |
13,405,081 |
13,421,951 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
8 |
34,763,710 |
34,808,634 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
multiple interactions |
ISO |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase, alpha 4 |
|
increases expression |
ISO |
9 |
78,039,773 |
78,057,156 |
RGD:6480464 |
CTD |
| G |
H2afv |
H2A histone family, member V |
|
decreases expression |
ISO |
11 |
6,327,229 |
6,344,446 |
RGD:6480464 |
CTD |
| G |
Hgf |
hepatocyte growth factor |
|
multiple interactions |
EXP |
5 |
16,059,368 |
16,125,257 |
RGD:6480464 |
CTD |
| G |
Hilpda |
hypoxia inducible lipid droplet associated |
|
increases expression |
ISO |
6 |
29,222,488 |
29,225,449 |
RGD:6480464 |
CTD |
| G |
Hist1h2bk |
histone cluster 1, H2bk |
|
decreases expression |
ISO |
13 |
22,127,756 |
22,128,136 |
RGD:6480464 |
CTD |
| G |
Hk1 |
hexokinase 1 |
|
decreases expression |
ISO |
10 |
61,731,603 |
61,842,656 |
RGD:6480464 |
CTD |
| G |
Hmgcr |
3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
|
decreases expression |
ISO |
13 |
97,418,917 |
97,440,891 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 |
|
increases expression |
ISO |
3 |
98,084,354 |
98,114,661 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
8 |
77,617,517 |
77,624,492 |
RGD:6480464 |
CTD |
| G |
Hoxd1 |
homeobox D1 |
|
decreases expression |
ISO |
2 |
74,601,037 |
74,603,199 |
RGD:6480464 |
CTD |
| G |
Hrh4 |
histamine receptor H4 |
|
decreases expression |
ISO |
18 |
13,165,499 |
13,181,391 |
RGD:6480464 |
CTD |
| G |
Hs2st1 |
heparan sulfate 2-O-sulfotransferase 1 |
|
decreases expression |
ISO |
3 |
144,094,071 |
144,233,180 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
decreases expression |
ISO |
1 |
195,047,834 |
195,090,239 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
multiple interactions |
ISO |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
multiple interactions |
ISO |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
increases activity |
ISO |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock factor 1 |
|
increases activity |
ISO |
15 |
76,307,875 |
76,331,402 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
decreases expression |
ISO |
12 |
111,929,246 |
111,934,605 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
affects localization |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
multiple interactions |
ISO |
17 |
35,106,304 |
35,109,101 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1b |
heat shock protein 1B |
|
increases expression |
ISO |
17 |
35,093,374 |
35,096,183 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
increases expression |
ISO |
17 |
35,109,648 |
35,116,173 |
RGD:6480464 |
CTD |
| G |
Hspa4 |
heat shock protein 4 |
|
decreases expression |
ISO |
11 |
53,073,316 |
53,113,981 |
RGD:6480464 |
CTD |
| G |
Hspa8 |
heat shock protein 8 |
|
affects localization |
ISO |
9 |
40,609,356 |
40,613,282 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
9 |
20,820,404 |
20,833,241 |
RGD:6480464 |
CTD |
| G |
Idh1 |
isocitrate dehydrogenase 1 (NADP+), soluble |
|
increases expression |
ISO |
1 |
65,205,190 |
65,233,053 |
RGD:6480464 |
CTD |
| G |
Ifi27l1 |
interferon, alpha-inducible protein 27 like 1 |
|
decreases expression |
ISO |
12 |
104,672,399 |
104,678,455 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
10 |
117,878,103 |
117,882,948 |
RGD:6480464 |
CTD |
| G |
Ifngr1 |
interferon gamma receptor 1 |
|
increases expression |
ISO |
10 |
19,311,764 |
19,330,031 |
RGD:6480464 |
CTD |
| G |
Ift57 |
intraflagellar transport 57 |
|
increases expression |
ISO |
16 |
49,699,407 |
49,765,239 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
10 |
87,321,801 |
87,399,792 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor I receptor |
|
multiple interactions |
ISO |
7 |
75,097,143 |
75,378,553 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
multiple interactions |
ISO |
2 |
129,125,346 |
129,135,708 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
decreases expression |
ISO |
2 |
129,125,346 |
129,135,708 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases secretion |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
2 |
129,190,315 |
129,196,856 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
multiple interactions |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il2 |
interleukin 2 |
|
increases expression |
ISO |
3 |
37,019,635 |
37,024,876 |
RGD:6480464 |
CTD |
| G |
Il23r |
interleukin 23 receptor |
|
decreases expression |
ISO |
6 |
67,372,926 |
67,441,849 |
RGD:6480464 |
CTD |
| G |
Il24 |
interleukin 24 |
|
decreases expression |
ISO |
1 |
132,778,651 |
132,783,988 |
RGD:6480464 |
CTD |
| G |
Il4ra |
interleukin 4 receptor, alpha |
|
increases expression |
ISO |
7 |
132,695,796 |
132,722,988 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
decreases expression |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
5 |
30,339,701 |
30,346,508 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
multiple interactions |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il6st |
interleukin 6 signal transducer |
|
decreases expression |
ISO |
13 |
113,254,278 |
113,297,068 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
increases secretion |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
multiple interactions |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Il8 |
interleukin 8 |
|
decreases expression |
ISO |
5 |
91,223,560 |
91,232,093 |
RGD:6480464 |
CTD |
| G |
Ints6 |
integrator complex subunit 6 |
|
increases expression |
ISO |
14 |
63,295,162 |
63,379,949 |
RGD:6480464 |
CTD |
| G |
Iqgap2 |
IQ motif containing GTPase activating protein 2 |
|
increases expression |
ISO |
13 |
96,397,132 |
96,661,877 |
RGD:6480464 |
CTD |
| G |
Jph3 |
junctophilin 3 |
|
increases expression |
ISO |
8 |
124,254,463 |
124,314,721 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
multiple interactions |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases activity |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Jun |
Jun oncogene |
|
increases phosphorylation |
ISO |
4 |
94,715,727 |
94,718,913 |
RGD:6480464 |
CTD |
| G |
Kat8 |
K(lysine) acetyltransferase 8 |
|
increases expression |
ISO |
7 |
135,056,031 |
135,069,276 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
ISO |
9 |
32,122,368 |
32,151,822 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
increases expression |
ISO |
6 |
142,513,459 |
142,519,876 |
RGD:6480464 |
CTD |
| G |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
|
increases expression |
ISO |
7 |
150,293,159 |
150,612,947 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain protein receptor |
|
decreases expression |
ISO |
5 |
76,329,290 |
76,374,453 |
RGD:6480464 |
CTD |
| G |
Kir3dl2 |
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
|
decreases expression |
ISO |
X |
132,982,646 |
133,003,580 |
RGD:6480464 |
CTD |
| G |
Klf15 |
Kruppel-like factor 15 |
|
increases expression |
ISO |
6 |
90,412,620 |
90,425,203 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
ISO |
19 |
23,215,716 |
23,241,401 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
decreases activity |
ISO |
7 |
51,052,947 |
51,059,192 |
RGD:6480464 |
CTD |
| G |
Klrc3 |
killer cell lectin-like receptor subfamily C, member 3 |
|
decreases expression |
ISO |
6 |
129,589,103 |
129,593,306 |
RGD:6480464 |
CTD |
| G |
Lama4 |
laminin, alpha 4 |
|
decreases expression |
ISO |
10 |
38,685,647 |
38,829,937 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
decreases expression |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lep |
leptin |
|
multiple interactions |
ISO |
6 |
29,010,221 |
29,023,876 |
RGD:6480464 |
CTD |
| G |
Lilra5 |
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
|
decreases expression |
ISO |
7 |
4,189,356 |
4,195,065 |
RGD:6480464 |
CTD |
| G |
Lpin2 |
lipin 2 |
|
decreases expression |
ISO |
17 |
71,533,318 |
71,599,158 |
RGD:6480464 |
CTD |
| G |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
|
increases expression |
ISO |
6 |
93,625,449 |
94,233,898 |
RGD:6480464 |
CTD |
| G |
Mal |
myelin and lymphocyte protein, T cell differentiation protein |
|
increases expression |
ISO |
2 |
127,458,962 |
127,482,431 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen-activated protein kinase kinase 1 |
|
increases phosphorylation |
ISO |
9 |
64,033,600 |
64,101,412 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
10 |
80,568,692 |
80,587,442 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
10 |
80,568,692 |
80,587,442 |
RGD:6480464 |
CTD |
| G |
Map2k2 |
mitogen-activated protein kinase kinase 2 |
|
increases phosphorylation |
ISO |
10 |
80,568,692 |
80,587,442 |
RGD:6480464 |
CTD |
| G |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
|
decreases expression |
ISO |
13 |
112,536,641 |
112,599,191 |
RGD:6480464 |
CTD |
| G |
Map3k13 |
mitogen-activated protein kinase kinase kinase 13 |
|
decreases expression |
ISO |
16 |
21,892,042 |
21,931,950 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
16 |
16,983,475 |
17,047,546 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
7 |
133,903,140 |
133,909,330 |
RGD:6480464 |
CTD |
| G |
Mapk7 |
mitogen-activated protein kinase 7 |
|
increases expression |
ISO |
11 |
61,302,314 |
61,307,715 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
increases phosphorylation |
ISO |
14 |
34,191,084 |
34,260,344 |
RGD:6480464 |
CTD |
| G |
Mbnl2 |
muscleblind-like 2 |
|
decreases expression |
ISO |
14 |
120,674,891 |
120,830,920 |
RGD:6480464 |
CTD |
| G |
Mllt4 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
|
increases expression |
ISO |
17 |
13,897,548 |
14,042,801 |
RGD:6480464 |
CTD |
| G |
Mmp9 |
matrix metallopeptidase 9 |
|
multiple interactions |
ISO |
2 |
164,773,751 |
164,781,346 |
RGD:6480464 |
CTD |
| G |
Mog |
myelin oligodendrocyte glycoprotein |
|
decreases expression |
ISO |
17 |
37,147,685 |
37,160,343 |
RGD:6480464 |
CTD |
| G |
Mphosph6 |
M phase phosphoprotein 6 |
|
decreases expression |
ISO |
8 |
120,315,545 |
120,325,829 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
decreases expression |
ISO |
15 |
78,237,142 |
78,244,445 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle and microspikes RAS |
|
multiple interactions |
ISO |
9 |
99,285,839 |
99,337,131 |
RGD:6480464 |
CTD |
| G |
Mras |
muscle and microspikes RAS |
|
increases activity |
ISO |
9 |
99,285,839 |
99,337,131 |
RGD:6480464 |
CTD |
| G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
|
increases expression |
ISO |
11 |
120,345,983 |
120,350,068 |
RGD:6480464 |
CTD |
| G |
Mst1 |
macrophage stimulating 1 (hepatocyte growth factor-like) |
|
decreases expression |
ISO |
9 |
107,982,767 |
107,987,358 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
decreases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
EXP |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
multiple interactions |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt1 |
metallothionein 1 |
|
increases expression |
ISO |
8 |
96,702,989 |
96,704,227 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
multiple interactions |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mt2 |
metallothionein 2 |
|
increases expression |
ISO |
8 |
96,696,518 |
96,697,467 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
multiple interactions |
ISO |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
multiple interactions |
ISO |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
increases activity |
ISO |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
increases expression |
ISO |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
multiple interactions |
ISO |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mtf1 |
metal response element binding transcription factor 1 |
|
increases expression |
EXP |
4 |
124,479,793 |
124,527,044 |
RGD:6480464 |
CTD |
| G |
Mthfd1 |
methylenetetrahydrofolate dehydrogenase (NADP+ dependent), methenyltetrahydrofolate cyclohydrolase, formyltetrahydrofolate synthase |
|
decreases expression |
ISO |
12 |
77,356,219 |
77,420,807 |
RGD:6480464 |
CTD |
| G |
Mtus1 |
mitochondrial tumor suppressor 1 |
|
increases expression |
ISO |
8 |
42,076,266 |
42,219,080 |
RGD:6480464 |
CTD |
| G |
Mx1 |
myxovirus (influenza virus) resistance 1 |
|
increases expression |
ISO |
16 |
97,668,642 |
97,684,513 |
RGD:6480464 |
CTD |
| G |
Myh7 |
myosin, heavy polypeptide 7, cardiac muscle, beta |
|
increases expression |
ISO |
14 |
55,589,525 |
55,613,386 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
increases expression |
ISO |
10 |
127,097,974 |
127,103,759 |
RGD:6480464 |
CTD |
| G |
Ncln |
nicalin homolog (zebrafish) |
|
increases expression |
ISO |
10 |
80,949,204 |
80,959,108 |
RGD:6480464 |
CTD |
| G |
Necab2 |
N-terminal EF-hand calcium binding protein 2 |
|
increases expression |
ISO |
8 |
121,970,619 |
121,996,535 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4 |
|
increases expression |
EXP |
9 |
72,510,154 |
72,597,655 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4 |
|
multiple interactions |
ISO |
9 |
72,510,154 |
72,597,655 |
RGD:6480464 |
CTD |
| G |
Nedd4 |
neural precursor cell expressed, developmentally down-regulated 4 |
|
increases expression |
ISO |
9 |
72,510,154 |
72,597,655 |
RGD:6480464 |
CTD |
| G |
Nefm |
neurofilament, medium polypeptide |
|
increases expression |
ISO |
14 |
68,737,602 |
68,743,061 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
|
affects expression |
ISO |
3 |
135,247,619 |
135,354,511 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
|
multiple interactions |
ISO |
12 |
56,590,396 |
56,593,634 |
RGD:6480464 |
CTD |
| G |
Nfkbib |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, beta |
|
decreases expression |
ISO |
7 |
29,543,270 |
29,551,543 |
RGD:6480464 |
CTD |
| G |
Nkx3-2 |
NK3 homeobox 2 |
|
increases expression |
ISO |
5 |
42,152,722 |
42,155,459 |
RGD:6480464 |
CTD |
| G |
Npas2 |
neuronal PAS domain protein 2 |
|
decreases expression |
ISO |
1 |
39,251,117 |
39,420,085 |
RGD:6480464 |
CTD |
| G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
|
increases expression |
ISO |
14 |
19,036,570 |
19,071,620 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
multiple interactions |
ISO |
8 |
32,928,500 |
33,028,675 |
RGD:6480464 |
CTD |
| G |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
|
increases expression |
ISO |
4 |
6,323,354 |
6,381,418 |
RGD:6480464 |
CTD |
| G |
Ocln |
occludin |
|
multiple interactions |
ISO |
13 |
101,267,322 |
101,322,453 |
RGD:6480464 |
CTD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase) |
|
increases expression |
ISO |
X |
98,835,403 |
98,879,690 |
RGD:6480464 |
CTD |
| G |
Pabpn1 |
poly(A) binding protein, nuclear 1 |
|
multiple interactions |
ISO |
14 |
55,512,980 |
55,517,764 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
increases cleavage |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
multiple interactions |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Parp1 |
poly (ADP-ribose) polymerase family, member 1 |
|
decreases expression |
ISO |
1 |
182,499,106 |
182,531,385 |
RGD:6480464 |
CTD |
| G |
Pcdhb20 |
protocadherin beta 20 |
|
increases expression |
ISO |
18 |
37,663,918 |
37,667,314 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
2 |
132,075,022 |
132,078,916 |
RGD:6480464 |
CTD |
| G |
Pde8a |
phosphodiesterase 8A |
|
decreases expression |
ISO |
7 |
88,358,690 |
88,478,508 |
RGD:6480464 |
CTD |
| G |
Pdia6 |
protein disulfide isomerase associated 6 |
|
decreases expression |
ISO |
12 |
17,273,401 |
17,291,576 |
RGD:6480464 |
CTD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isoenzyme 2 |
|
increases expression |
ISO |
11 |
94,887,572 |
94,902,685 |
RGD:6480464 |
CTD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
|
increases expression |
ISO |
6 |
5,433,351 |
5,446,278 |
RGD:6480464 |
CTD |
| G |
Pdlim7 |
PDZ and LIM domain 7 |
|
decreases expression |
ISO |
13 |
55,598,848 |
55,614,800 |
RGD:6480464 |
CTD |
| G |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
|
increases expression |
ISO |
4 |
11,885,332 |
11,893,597 |
RGD:6480464 |
CTD |
| G |
Pdp2 |
pyruvate dehyrogenase phosphatase catalytic subunit 2 |
|
decreases expression |
ISO |
8 |
107,115,368 |
107,120,749 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
decreases expression |
ISO |
1 |
132,585,620 |
132,625,830 |
RGD:6480464 |
CTD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
increases expression |
ISO |
2 |
11,393,057 |
11,475,556 |
RGD:6480464 |
CTD |
| G |
Pfkl |
phosphofructokinase, liver, B-type |
|
decreases expression |
ISO |
10 |
77,449,692 |
77,472,541 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
decreases expression |
ISO |
15 |
97,923,020 |
97,962,878 |
RGD:6480464 |
CTD |
| G |
Pgap2 |
post-GPI attachment to proteins 2 |
|
decreases expression |
ISO |
7 |
109,371,588 |
109,386,277 |
RGD:6480464 |
CTD |
| G |
Pgk1 |
phosphoglycerate kinase 1 |
|
increases expression |
ISO |
X |
103,382,463 |
103,399,038 |
RGD:6480464 |
CTD |
| G |
Phf7 |
PHD finger protein 7 |
|
decreases expression |
ISO |
14 |
32,050,882 |
32,064,404 |
RGD:6480464 |
CTD |
| G |
Pim3 |
proviral integration site 3 |
|
increases expression |
ISO |
15 |
88,692,624 |
88,696,156 |
RGD:6480464 |
CTD |
| G |
Pkia |
protein kinase inhibitor, alpha |
|
increases expression |
ISO |
3 |
7,366,604 |
7,445,366 |
RGD:6480464 |
CTD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
increases expression |
ISO |
1 |
151,676,752 |
151,808,414 |
RGD:6480464 |
CTD |
| G |
Plcb4 |
phospholipase C, beta 4 |
|
increases expression |
ISO |
2 |
135,567,566 |
135,838,804 |
RGD:6480464 |
CTD |
| G |
Plch1 |
phospholipase C, eta 1 |
|
decreases expression |
ISO |
3 |
63,500,156 |
63,654,913 |
RGD:6480464 |
CTD |
| G |
Pnma2 |
paraneoplastic antigen MA2 |
|
decreases expression |
ISO |
14 |
67,530,045 |
67,538,898 |
RGD:6480464 |
CTD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
increases expression |
ISO |
5 |
136,165,084 |
136,211,195 |
RGD:6480464 |
CTD |
| G |
Pou4f2 |
POU domain, class 4, transcription factor 2 |
|
decreases expression |
ISO |
8 |
80,956,908 |
80,960,551 |
RGD:6480464 |
CTD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
multiple interactions |
EXP |
15 |
85,565,994 |
85,637,281 |
RGD:6480464 |
CTD |
| G |
Ppm1b |
protein phosphatase 1B, magnesium dependent, beta isoform |
|
decreases expression |
ISO |
17 |
85,356,081 |
85,423,332 |
RGD:6480464 |
CTD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory (inhibitor) subunit 3C |
|
increases expression |
ISO |
19 |
36,806,221 |
36,811,094 |
RGD:6480464 |
CTD |
| G |
Ppp2r2d |
protein phosphatase 2, regulatory subunit B, delta isoform |
|
increases expression |
ISO |
7 |
146,038,069 |
146,074,740 |
RGD:6480464 |
CTD |
| G |
Prpsap2 |
phosphoribosyl pyrophosphate synthetase-associated protein 2 |
|
increases expression |
ISO |
11 |
61,543,152 |
61,575,590 |
RGD:6480464 |
CTD |
| G |
Prr3 |
proline-rich polypeptide 3 |
|
increases expression |
ISO |
17 |
36,109,484 |
36,116,770 |
RGD:6480464 |
CTD |
| G |
Psmb2 |
proteasome (prosome, macropain) subunit, beta type 2 |
|
decreases expression |
ISO |
4 |
126,354,887 |
126,386,959 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
protease (prosome, macropain) 26S subunit, ATPase 5 |
|
decreases expression |
ISO |
11 |
106,117,499 |
106,124,426 |
RGD:6480464 |
CTD |
| G |
Ptcra |
pre T cell antigen receptor alpha |
|
decreases expression |
ISO |
17 |
46,892,612 |
46,900,661 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
EXP |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases response to substance |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
increases ubiquitination |
ISO |
19 |
32,832,067 |
32,900,650 |
RGD:6480464 |
CTD |
| G |
Ptges2 |
prostaglandin E synthase 2 |
|
increases expression |
ISO |
2 |
32,251,410 |
32,258,260 |
RGD:6480464 |
CTD |
| G |
Ptpn1 |
protein tyrosine phosphatase, non-receptor type 1 |
|
decreases activity |
ISO |
2 |
167,757,827 |
167,804,885 |
RGD:6480464 |
CTD |
| G |
Ptprn |
protein tyrosine phosphatase, receptor type, N |
|
increases expression |
ISO |
1 |
75,243,616 |
75,260,783 |
RGD:6480464 |
CTD |
| G |
Pts |
6-pyruvoyl-tetrahydropterin synthase |
|
decreases expression |
ISO |
9 |
50,329,722 |
50,336,746 |
RGD:6480464 |
CTD |
| G |
Pxk |
PX domain containing serine/threonine kinase |
|
increases expression |
ISO |
14 |
8,930,727 |
8,997,625 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
increases expression |
ISO |
8 |
11,453,977 |
11,478,499 |
RGD:6480464 |
CTD |
| G |
Rasgrf1 |
RAS protein-specific guanine nucleotide-releasing factor 1 |
|
decreases expression |
ISO |
9 |
89,804,613 |
89,921,817 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
ISO |
14 |
73,595,309 |
73,725,598 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
decreases activity |
ISO |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
19 |
5,637,490 |
5,648,130 |
RGD:6480464 |
CTD |
| G |
Repin1 |
replication initiator 1 |
|
increases expression |
ISO |
6 |
48,543,882 |
48,549,081 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin |
|
multiple interactions |
EXP |
X |
20,126,944 |
20,139,213 |
RGD:6480464 |
CTD |
| G |
Rgn |
regucalcin |
|
increases expression |
EXP |
X |
20,126,944 |
20,139,213 |
RGD:6480464 |
CTD |
| G |
Rgp1 |
RGP1 retrograde golgi transport homolog (S. cerevisiae) |
|
increases expression |
ISO |
4 |
43,591,607 |
43,600,359 |
RGD:6480464 |
CTD |
| G |
Rgs19 |
regulator of G-protein signaling 19 |
|
decreases expression |
ISO |
2 |
181,423,128 |
181,428,629 |
RGD:6480464 |
CTD |
| G |
Rims2 |
regulating synaptic membrane exocytosis 2 |
|
decreases expression |
ISO |
15 |
39,029,878 |
39,513,486 |
RGD:6480464 |
CTD |
| G |
Rny1 |
RNA, Y1 small cytoplasmic, Ro-associated |
|
decreases degradation |
ISO |
6 |
47,738,069 |
47,738,179 |
RGD:6480464 |
CTD |
| G |
Rny3 |
RNA, Y3 small cytoplasmic (associated with Ro protein) |
|
decreases degradation |
ISO |
6 |
47,731,623 |
47,731,723 |
RGD:6480464 |
CTD |
| G |
Ror1 |
receptor tyrosine kinase-like orphan receptor 1 |
|
decreases expression |
ISO |
4 |
99,768,396 |
100,115,150 |
RGD:6480464 |
CTD |
| G |
Rps6ka2 |
ribosomal protein S6 kinase, polypeptide 2 |
|
increases expression |
ISO |
17 |
7,374,464 |
7,507,664 |
RGD:6480464 |
CTD |
| G |
Rps6ka6 |
ribosomal protein S6 kinase polypeptide 6 |
|
increases expression |
ISO |
X |
108,501,801 |
108,651,554 |
RGD:6480464 |
CTD |
| G |
Rrh |
retinal pigment epithelium derived rhodopsin homolog |
|
increases expression |
ISO |
3 |
129,511,493 |
129,525,423 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt related transcription factor 2 |
|
multiple interactions |
EXP |
17 |
44,740,950 |
44,951,746 |
RGD:6480464 |
CTD |
| G |
Runx2 |
runt related transcription factor 2 |
|
increases expression |
EXP |
17 |
44,740,950 |
44,951,746 |
RGD:6480464 |
CTD |
| G |
Sag |
retinal S-antigen |
|
decreases expression |
ISO |
1 |
89,700,255 |
89,741,732 |
RGD:6480464 |
CTD |
| G |
Scg3 |
secretogranin III |
|
increases expression |
ISO |
9 |
75,491,173 |
75,531,863 |
RGD:6480464 |
CTD |
| G |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
|
increases expression |
ISO |
2 |
66,108,839 |
66,278,894 |
RGD:6480464 |
CTD |
| G |
Sema6b |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6B |
|
increases expression |
ISO |
17 |
56,262,508 |
56,279,766 |
RGD:6480464 |
CTD |
| G |
Sept11 |
septin 11 |
|
decreases expression |
ISO |
5 |
93,522,483 |
93,603,984 |
RGD:6480464 |
CTD |
| G |
Sept8 |
septin 8 |
|
decreases expression |
ISO |
11 |
53,333,302 |
53,357,598 |
RGD:6480464 |
CTD |
| G |
Serinc1 |
serine incorporator 1 |
|
decreases expression |
ISO |
10 |
57,235,580 |
57,252,335 |
RGD:6480464 |
CTD |
| G |
Sertad4 |
SERTA domain containing 4 |
|
increases expression |
ISO |
1 |
194,670,682 |
194,681,946 |
RGD:6480464 |
CTD |
| G |
Sesn2 |
sestrin 2 |
|
multiple interactions |
ISO |
4 |
132,048,719 |
132,066,371 |
RGD:6480464 |
CTD |
| G |
Sesn3 |
sestrin 3 |
|
decreases expression |
ISO |
9 |
14,080,745 |
14,130,578 |
RGD:6480464 |
CTD |
| G |
Sidt2 |
SID1 transmembrane family, member 2 |
|
increases expression |
ISO |
9 |
45,745,958 |
45,763,332 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
increases expression |
ISO |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc11a2 |
solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 |
|
multiple interactions |
ISO |
15 |
100,218,329 |
100,253,486 |
RGD:6480464 |
CTD |
| G |
Slc12a9 |
solute carrier family 12 (potassium/chloride transporters), member 9 |
|
increases expression |
ISO |
5 |
137,755,786 |
137,774,810 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
multiple interactions |
ISO |
19 |
59,335,368 |
59,370,502 |
RGD:6480464 |
CTD |
| G |
Slc18a2 |
solute carrier family 18 (vesicular monoamine), member 2 |
|
decreases expression |
ISO |
19 |
59,335,368 |
59,370,502 |
RGD:6480464 |
CTD |
| G |
Slc20a1 |
solute carrier family 20, member 1 |
|
decreases expression |
ISO |
2 |
129,024,509 |
129,037,351 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
EXP |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
EXP |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
affects localization |
EXP |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
EXP |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
decreases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a1 |
solute carrier family 30 (zinc transporter), member 1 |
|
increases expression |
ISO |
1 |
193,730,660 |
193,737,126 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
ISO |
4 |
133,898,985 |
133,908,580 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
affects localization |
EXP |
4 |
133,898,985 |
133,908,580 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
EXP |
4 |
133,898,985 |
133,908,580 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
decreases expression |
ISO |
4 |
133,898,985 |
133,908,580 |
RGD:6480464 |
CTD |
| G |
Slc30a2 |
solute carrier family 30 (zinc transporter), member 2 |
|
increases expression |
ISO |
4 |
133,898,985 |
133,908,580 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
affects localization |
EXP |
2 |
122,506,975 |
122,528,399 |
RGD:6480464 |
CTD |
| G |
Slc30a4 |
solute carrier family 30 (zinc transporter), member 4 |
|
decreases expression |
ISO |
2 |
122,506,975 |
122,528,399 |
RGD:6480464 |
CTD |
| G |
Slc39a1 |
solute carrier family 39 (zinc transporter), member 1 |
|
decreases expression |
ISO |
3 |
90,052,114 |
90,057,534 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
decreases expression |
ISO |
1 |
46,864,389 |
46,910,354 |
RGD:6480464 |
CTD |
| G |
Slc39a10 |
solute carrier family 39 (zinc transporter), member 10 |
|
increases expression |
ISO |
1 |
46,864,389 |
46,910,354 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
affects localization |
EXP |
10 |
80,491,285 |
80,496,657 |
RGD:6480464 |
CTD |
| G |
Slc39a3 |
solute carrier family 39 (zinc transporter), member 3 |
|
decreases expression |
EXP |
10 |
80,491,285 |
80,496,657 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
increases expression |
ISO |
8 |
95,484,946 |
95,525,566 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
multiple interactions |
ISO |
13 |
73,674,195 |
73,716,120 |
RGD:6480464 |
CTD |
| G |
Slc6a3 |
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
|
increases expression |
ISO |
13 |
73,674,195 |
73,716,120 |
RGD:6480464 |
CTD |
| G |
Slc9a6 |
solute carrier family 9 (sodium/hydrogen exchanger), member 6 |
|
increases expression |
ISO |
X |
53,863,012 |
53,917,407 |
RGD:6480464 |
CTD |
| G |
Slco1c1 |
solute carrier organic anion transporter family, member 1c1 |
|
increases expression |
ISO |
6 |
141,472,907 |
141,518,698 |
RGD:6480464 |
CTD |
| G |
Snrk |
SNF related kinase |
|
decreases expression |
ISO |
9 |
122,026,384 |
122,078,820 |
RGD:6480464 |
CTD |
| G |
Snrnp70 |
small nuclear ribonucleoprotein 70 (U1) |
|
decreases degradation |
ISO |
7 |
52,631,824 |
52,651,017 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
increases expression |
ISO |
10 |
94,874,124 |
94,879,491 |
RGD:6480464 |
CTD |
| G |
Sord |
sorbitol dehydrogenase |
|
decreases expression |
ISO |
2 |
122,060,575 |
122,091,073 |
RGD:6480464 |
CTD |
| G |
Spg7 |
spastic paraplegia 7 homolog (human) |
|
increases expression |
ISO |
8 |
125,589,408 |
125,621,651 |
RGD:6480464 |
CTD |
| G |
Sptbn1 |
spectrin beta, non-erythrocytic 1 |
|
decreases expression |
ISO |
11 |
29,999,395 |
30,119,772 |
RGD:6480464 |
CTD |
| G |
Src |
Rous sarcoma oncogene |
|
decreases activity |
ISO |
2 |
157,250,029 |
157,297,574 |
RGD:6480464 |
CTD |
| G |
Srsf5 |
serine/arginine-rich splicing factor 5 |
|
decreases expression |
ISO |
12 |
82,046,491 |
82,051,494 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
1 |
52,176,282 |
52,218,707 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 |
|
multiple interactions |
ISO |
11 |
100,748,124 |
100,800,825 |
RGD:6480464 |
CTD |
| G |
Steap4 |
STEAP family member 4 |
|
decreases expression |
ISO |
5 |
7,960,472 |
7,982,213 |
RGD:6480464 |
CTD |
| G |
Sulf1 |
sulfatase 1 |
|
increases expression |
ISO |
1 |
12,708,626 |
12,850,453 |
RGD:6480464 |
CTD |
| G |
Sult1a1 |
sulfotransferase family 1A, phenol-preferring, member 1 |
|
increases expression |
ISO |
7 |
133,816,384 |
133,819,871 |
RGD:6480464 |
CTD |
| G |
Synrg |
synergin, gamma |
|
increases expression |
ISO |
11 |
83,777,930 |
83,855,591 |
RGD:6480464 |
CTD |
| G |
Tas1r3 |
taste receptor, type 1, member 3 |
|
affects response to substance |
EXP |
4 |
155,233,377 |
155,237,462 |
RGD:6480464 |
CTD |
| G |
Tas2r144 |
taste receptor, type 2, member 144 |
|
increases expression |
ISO |
6 |
42,165,327 |
42,166,286 |
RGD:6480464 |
CTD |
| G |
Tbc1d8 |
TBC1 domain family, member 8 |
|
increases expression |
ISO |
1 |
39,428,340 |
39,535,592 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
decreases expression |
ISO |
5 |
120,120,678 |
120,134,610 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
decreases expression |
ISO |
10 |
80,791,476 |
80,797,917 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
multiple interactions |
ISO |
7 |
150,078,681 |
150,085,871 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
decreases expression |
ISO |
7 |
150,078,681 |
150,085,871 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
decreases expression |
ISO |
2 |
148,230,207 |
148,233,924 |
RGD:6480464 |
CTD |
| G |
Timp3 |
tissue inhibitor of metalloproteinase 3 |
|
increases expression |
ISO |
10 |
85,763,157 |
85,812,250 |
RGD:6480464 |
CTD |
| G |
Tll1 |
tolloid-like |
|
decreases expression |
ISO |
8 |
66,493,567 |
66,684,790 |
RGD:6480464 |
CTD |
| G |
Tll2 |
tolloid-like 2 |
|
increases expression |
ISO |
19 |
41,158,471 |
41,281,264 |
RGD:6480464 |
CTD |
| G |
Tmem184c |
transmembrane protein 184C |
|
decreases expression |
ISO |
8 |
80,119,877 |
80,134,552 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
affects expression |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
17 |
35,336,335 |
35,338,941 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
increases expression |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tnfsf11 |
tumor necrosis factor (ligand) superfamily, member 11 |
|
multiple interactions |
EXP |
14 |
78,677,253 |
78,707,850 |
RGD:6480464 |
CTD |
| G |
Tpm4 |
tropomyosin 4 |
|
decreases expression |
ISO |
8 |
74,659,191 |
74,677,028 |
RGD:6480464 |
CTD |
| G |
Trem1 |
triggering receptor expressed on myeloid cells 1 |
|
decreases expression |
ISO |
17 |
48,371,922 |
48,386,091 |
RGD:6480464 |
CTD |
| G |
Trim31 |
tripartite motif-containing 31 |
|
decreases expression |
ISO |
17 |
37,035,075 |
37,047,162 |
RGD:6480464 |
CTD |
| G |
Trove2 |
TROVE domain family, member 2 |
|
decreases expression |
ISO |
1 |
145,597,920 |
145,624,181 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trp53 |
transformation related protein 53 |
|
multiple interactions |
ISO |
11 |
69,393,861 |
69,405,375 |
RGD:6480464 |
CTD |
| G |
Trpm5 |
transient receptor potential cation channel, subfamily M, member 5 |
|
affects response to substance |
EXP |
7 |
150,257,434 |
150,280,547 |
RGD:6480464 |
CTD |
| G |
Trpv1 |
transient receptor potential cation channel, subfamily V, member 1 |
|
increases activity |
ISO |
11 |
73,051,761 |
73,074,009 |
RGD:6480464 |
CTD |
| G |
Tsc22d1 |
TSC22 domain family, member 1 |
|
increases expression |
ISO |
14 |
76,815,628 |
76,907,573 |
RGD:6480464 |
CTD |
| G |
Tsr1 |
TSR1 20S rRNA accumulation |
|
increases expression |
ISO |
11 |
74,711,582 |
74,722,842 |
RGD:6480464 |
CTD |
| G |
Txndc12 |
thioredoxin domain containing 12 (endoplasmic reticulum) |
|
decreases expression |
ISO |
4 |
108,507,283 |
108,534,725 |
RGD:6480464 |
CTD |
| G |
Ube2g2 |
ubiquitin-conjugating enzyme E2G 2 |
|
decreases expression |
ISO |
10 |
77,085,066 |
77,108,735 |
RGD:6480464 |
CTD |
| G |
Ube2i |
ubiquitin-conjugating enzyme E2I |
|
increases expression |
ISO |
17 |
25,397,456 |
25,411,255 |
RGD:6480464 |
CTD |
| G |
Ucp3 |
uncoupling protein 3 (mitochondrial, proton carrier) |
|
increases expression |
ISO |
7 |
107,621,500 |
107,634,941 |
RGD:6480464 |
CTD |
| G |
Ugcg |
UDP-glucose ceramide glucosyltransferase |
|
increases expression |
ISO |
4 |
59,202,422 |
59,235,705 |
RGD:6480464 |
CTD |
| G |
Unc119 |
unc-119 homolog (C. elegans) |
|
increases expression |
ISO |
11 |
78,157,024 |
78,162,658 |
RGD:6480464 |
CTD |
| G |
Usp44 |
ubiquitin specific peptidase 44 |
|
decreases expression |
ISO |
10 |
93,294,300 |
93,311,283 |
RGD:6480464 |
CTD |
| G |
Vdac1 |
voltage-dependent anion channel 1 |
|
multiple interactions |
ISO |
11 |
52,174,617 |
52,202,898 |
RGD:6480464 |
CTD |
| G |
Vdac2 |
voltage-dependent anion channel 2 |
|
multiple interactions |
ISO |
14 |
22,650,783 |
22,665,101 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
17 |
46,153,942 |
46,169,326 |
RGD:6480464 |
CTD |
| G |
Vegfc |
vascular endothelial growth factor C |
|
decreases expression |
ISO |
8 |
55,162,886 |
55,271,808 |
RGD:6480464 |
CTD |
| G |
Vps33b |
vacuolar protein sorting 33B (yeast) |
|
increases expression |
ISO |
7 |
87,414,541 |
87,436,465 |
RGD:6480464 |
CTD |
| G |
Wdr13 |
WD repeat domain 13 |
|
decreases expression |
ISO |
X |
7,700,427 |
7,709,984 |
RGD:6480464 |
CTD |
| G |
Wdr46 |
WD repeat domain 46 |
|
decreases expression |
ISO |
17 |
34,077,668 |
34,086,640 |
RGD:6480464 |
CTD |
| G |
Wipf2 |
WAS/WASL interacting protein family, member 2 |
|
increases expression |
ISO |
11 |
98,724,912 |
98,766,892 |
RGD:6480464 |
CTD |
| G |
Wnk2 |
WNK lysine deficient protein kinase 2 |
|
decreases expression |
ISO |
13 |
49,131,671 |
49,243,383 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
ISO |
17 |
74,233,248 |
74,299,522 |
RGD:6480464 |
CTD |
| G |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
|
decreases expression |
ISO |
17 |
5,492,600 |
5,753,891 |
RGD:6480464 |
CTD |
| G |
Zfp36 |
zinc finger protein 36 |
|
increases expression |
ISO |
7 |
29,161,803 |
29,164,247 |
RGD:6480464 |
CTD |
| G |
Zfp64 |
zinc finger protein 64 |
|
increases expression |
ISO |
2 |
168,750,861 |
168,781,087 |
RGD:6480464 |
CTD |
| G |
Zfp764 |
zinc finger protein 764 |
|
increases expression |
ISO |
7 |
134,547,182 |
134,550,336 |
RGD:6480464 |
CTD |
Term paths to the root
|